Avipep

Avipep is a privately owned biotechnology company developing ADCs for the treatment of cancer. Avipep's proprietary AvibodyTM products are engineered antibody related proteins that can deliver either cancer-killing drugs or cancer-imaging agents directly and specifically to tumours. Antibodies are natural proteins in the body's immune system that c... an target cancer cells by binding to specific molecules on the cancer-cell surface. AvibodyTM products leverage the targeting capacity of natural antibodies but are tuned for improved tumour targeting and in-vivo performance. To date the Company has generated pre-clinical animal results that suggest the exciting potential for the approach.Read More